Fighting Blindness Retinal Degeneration Fund Foundation serves as Executive at Opus Genetics, Inc., where they oversee executive responsibilities. Since joining the company, Fighting Blindness Retinal Degeneration Fund Foundation has executed 1 insider transactions totaling $8.6M, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 9, 2025 involved selling 4,000,000 shares valued at $8.6M.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Dec 9, 2025 | IRD | $8.6M | Sale | 4,000,000 | $2.15 | Discretionary |
Fighting Blindness Retinal Degeneration Fund Foundation currently holds 5,492,171 shares of Opus Genetics, Inc. (IRD), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Fighting Blindness Retinal Degeneration Fund Foundation has been a net seller of IRD stock. They have purchased $0 and sold $8.6M worth of shares.
Fighting Blindness Retinal Degeneration Fund Foundation's most recent insider trade was on Dec 9, 2025, when they sold 4,000,000 shares at $2.15 per share.
Get notified when new Form 4 filings are submitted